SCHEMBL25684453

SCHEMBL25684453

CCCc1cc2c(c3ccccc3n2C)c2c1sc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.37
▸ MAPT P10636 3/20 0.37
▸ TOP2A P11388 2/20 0.36
▸ UTS2R Q9UKP6 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ TSHR P16473 3/20 0.35
▸ HTT P42858 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ GFER P55789 1/20 0.34
▸ L3MBTL1 Q9Y468 3/20 0.34
▸ ATM Q13315 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ SLC2A1 P11166 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25683412 0.90 GPR3 (0.39) GPR3KDM4EMAPTTOP2AUTS2R
SCHEMBL25682420 0.84 KDM4E (0.39) GPR3KDM4EMAPTTOP2AUTS2R
SCHEMBL25683896 0.83 KDM4E (0.39) GPR3KDM4EMAPTALDH1A1TSHR
SCHEMBL25993677 0.80 GPR3 (0.40) GPR3KDM4EMAPTTOP2AALDH1A1
SCHEMBL25683590 0.79 L3MBTL1 (0.42) GPR3KDM4EMAPTTOP2AUTS2R
SCHEMBL25683410 0.78 MAPT (0.42) GPR3KDM4EMAPTALDH1A1TSHR
SCHEMBL25683989 0.78 MAPT (0.42) GPR3KDM4EMAPTALDH1A1TSHR
SCHEMBL25684159 0.77 GPR3 (0.40) GPR3KDM4EMAPTTOP2AUTS2R
SCHEMBL25682812 0.77 GPR3 (0.40) GPR3KDM4EMAPTTOP2AALDH1A1
SCHEMBL25684455 0.77 KDM4E (0.41) GPR3KDM4EMAPTUTS2RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed
US-20170157105-A1 Anti-Viral Compounds ABBVIE INC. (US) 2017-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170157105-A1 Anti-Viral Compounds HAVCR2, EIF2AK2, MAVS GPR3 4432/4885KDM4E 2318/4885MAPT 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback